Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dual Diagnosis”

36,900 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36,900 results

Not applicableStudy completedNCT06869824
What this trial is testing

The Efficacy of Minayo Iron-rich Nutritional Gummies on Female Anemia, Skin Condition and Qi-blood Deficiency Syndrome

Who this might be right for
AnemiaSkin ConditionQi-blood Deficiency Syndrome
Hangzhou Agile Groups Network Technology Co., Ltd. 36
Early research (Phase 1)Study completedNCT04483024
What this trial is testing

Effects of Chicken Extract and Collagen on Mobility

Who this might be right for
Knee OsteoarthritisMuscle Loss
Shan May Yong 160
Not applicableLooking for participantsNCT06051123
What this trial is testing

Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients

Who this might be right for
ALSFTDALS (Amyotrophic Lateral Sclerosis)Frontal Temporal Dementia (FTD)
Centre hospitalier de l'Université de Montréal (CHUM) 150
Large-scale testing (Phase 3)Study completedNCT04504396
What this trial is testing

Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
PegBio Co., Ltd. 620
Large-scale testing (Phase 3)Active Not RecruitingNCT05063162
What this trial is testing

Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOGAD)

Who this might be right for
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
UCB Biopharma SRL 113
Large-scale testing (Phase 3)Study completedNCT01269788
What this trial is testing

Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-blind Placebo-controlled Clinical Trial

Who this might be right for
Non-erosive Reflux Disease
Tehran University of Medical Sciences 144
Large-scale testing (Phase 3)Looking for participantsNCT07052903
What this trial is testing

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Who this might be right for
Transthyretin Amyloidosis With Cardiomyopathy
Alnylam Pharmaceuticals 1,750
Not applicableActive Not RecruitingNCT02481427
What this trial is testing

Finnish Unicompartmental and Total Knee Arthroplasty Investigation

Who this might be right for
Osteoarthritis, Knee
Turku University Hospital 140
Early research (Phase 1)Study completedNCT03798561
What this trial is testing

Study to Evaluate ASN008 Topical Gel (TG)

Who this might be right for
Dermatitis, AtopicPruritusDermatitis Eczema
Asana BioSciences 24
Large-scale testing (Phase 3)Study completedNCT00068861
What this trial is testing

Treatment of Infertility in Women With Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary SyndromeInfertilityPregnancy
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 678
Testing effectiveness (Phase 2)Study completedNCT01782742
What this trial is testing

Bexarotene Amyloid Treatment for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
The Cleveland Clinic 20
Large-scale testing (Phase 3)Study completedNCT00827242
What this trial is testing

Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily

Who this might be right for
Benign Prostatic Hyperplasia
Eli Lilly and Company 325
Testing effectiveness (Phase 2)Study completedNCT02054286
What this trial is testing

Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).

Who this might be right for
HIV Infection
Theravectys S.A. 38
Not applicableStudy completedNCT03469986
What this trial is testing

A Multi-site Comparison of Social Visual Engagement to Clinical Diagnosis for Autism Spectrum Disorder

Who this might be right for
Autism Spectrum Disorder
EarliTec Diagnostics, Inc 505
Large-scale testing (Phase 3)Study completedNCT03399370
What this trial is testing

Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol

Who this might be right for
ASCVDElevated Cholesterol
The Medicines Company 1,561
Large-scale testing (Phase 3)Study completedNCT02181673
What this trial is testing

Golimumab in Participants With Active Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
Janssen Research & Development, LLC 480
Post-approval studies (Phase 4)Study completedNCT00406354
What this trial is testing

Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany

Who this might be right for
Attention Deficit Hyperactivity DisorderOppositional Defiant Disorder
Eli Lilly and Company 181
Early research (Phase 1)Study completedNCT03213405
What this trial is testing

Assess Safety, Tolerability and Immunogenicity of the Live Attenuated hRSV Vaccine rBCG-N-hRSV

Who this might be right for
Respiratory Syncytial Virus Infections
Pontificia Universidad Catolica de Chile 24
Testing effectiveness (Phase 2)Study completedNCT06102005
What this trial is testing

Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma

Who this might be right for
Asthma
Sanofi 685
Not applicableUnknownNCT02079194
What this trial is testing

Comparison Between P2Y12 Antagonist Monotherapy and Dual Antiplatelet Therapy After DES

Who this might be right for
Coronary Artery Disease
Samsung Medical Center 3,000
Next Page